The drugmakers said they are seeing “encouraging data” from their ongoing booster shot trial. They also said the shot provides five to 10 times more neutralizing antibodies when administered six months after the second dose, according to early analysis.
Pfizer and BioNTech said they plan to publish more definitive data in a peer-reviewed journal and will submit the data to regulatory authorities “in the coming weeks.” They also said they plan to launch clinical trials in August testing an updated version of the vaccine designed to provide better protection against the delta variant first detected in India.
On the same day as Pfizer and BioNTech announced their plans, the CDC and FDA released a joint statement saying Americans who have been fully vaccinated against COVID-19 do not need booster shots at this time.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
